Cellyan Biotechnology Co., Ltd (HKPD) stock
HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
$0.11+0.00 (+1.81%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Cellyan Biotechnology net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2026 it was -$1.14M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$1.14M | – |
| FY2025 | Mar 31, 2025 | -$27.06K | -102.0% |
| FY2024 | Mar 31, 2024 | $1.33M | +33.2% |
| FY2023 | Mar 31, 2023 | $998.20K | – |
See a number that looks wrong?